CanFite Biopharma (CANF)
(Delayed Data from AMEX)
$2.04 USD
+0.06 (3.03%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $2.05 +0.01 (0.49%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
09/26/2024
Time: -- |
6/2024 | $-0.36 | 0.00% |
Earnings Summary
For their last quarter, CanFite Biopharma (CANF) reported earnings of -$0.31 per share, missing the Zacks Consensus Estimate of -$0.27 per share. This reflects a negative earnings surprise of 14.81%. Look out for CANF's next earnings release expected on September 26, 2024. For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year increase of 10%.
Earnings History
Price & Consensus
Zacks News for CANF
Can-Fite Biopharma Ltd (CANF) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
CANF: What are Zacks experts saying now?
Zacks Private Portfolio Services